Bedrijf laden
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 3 november 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
US$ 205,9M
-3,6% y/y
-7,8% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker CoUS$ 14,2BA
MKCMccormick & Company, IncorporatedUS$ 12,7BA+
FRPTFreshpet, Inc.US$ 3,3BA
DARDarling Ingredients Inc.US$ 8,7BB+
POSTPost Holdings, Inc.US$ 3,6BB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30 jul 2026BAGraded B, now A
MDLZMondelez International, Inc.29 okt 2026CAGraded C, now A
HSYHershey Co.29 okt 2026BAGraded B, now A
SYYSysco Corporation4 nov 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.4 nov 2026BAGraded B, now A
Gebouwd uit de eigen deponeringen van Usana Health Sciences, Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
